Medicare Enrolled

Dr. James Leake

Radiation Oncology · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
601 E 15TH ST, Austin, TX 78701
5123248355
In practice since 2014 (11 years)
NPI: 1629498217 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leake from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leake? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leake

Dr. James Leake is a radiation oncology specialist in Austin, TX, with 11 years of NPI registration. Based on federal Medicare data, Dr. Leake performed 11,061 Medicare services across 2,240 unique beneficiaries.

Between the years covered by Open Payments, Dr. Leake received a total of $91 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leake is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 7% volume in TX $91 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,061
Medicare services
Top 7% in TX for radiation oncology
2,240
Unique beneficiaries
$134
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,006 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based) 4,850 $0 $1
Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie 3,200 $194 $497
Nuclear medicine study from skull base to mid-thigh with ct scan 531 $602 $2,212
Gallium ga-68, dotatate, diagnostic, 0.1 millicurie 390 $115 $397
Chest X-ray, 1 view 371 $7 $129
Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie 370 $770 $2,744
CT scan of abdomen and pelvis with contrast 145 $129 $681
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 139 $90 $374
Ct scan of chest with contrast 136 $56 $287
Piflufolastat f-18, diagnostic, 1 millicurie 120 $515 $1,889
Nuclear medicine study whole body with ct scan 67 $376 $1,564
Blood creatinine level 60 $5 $21
X-ray of abdomen, 1 view 58 $7 $120
Ct scan of blood vessels of chest with contrast 51 $65 $1,316
Chest X-ray, 2 views 39 $10 $62
Nuclear medicine study of lung ventilation and circulation 37 $38 $694
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 37 $36 $138
CT scan of chest, without contrast 34 $58 $260
Ct scan of abdomen and pelvis without contrast 31 $81 $522
Ultrasound study of one arm or leg veins with compression and maneuvers 31 $16 $418
X-ray of pelvis, 1-2 views 29 $6 $121
Nuclear medicine study of bone and/or joint whole body 25 $201 $739
Nuclear medicine study of liver and bile duct system 23 $27 $526
Radioactive drug therapy through a vein 21 $122 $629
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging 19 $300 $1,231
Limited ultrasound scan of abdomen 18 $19 $382
Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries 18 $1,952 $6,814
Shoulder X-ray, 2+ views 17 $7 $133
Hip X-ray, 2-3 views 17 $8 $212
Ultrasound scan of head and neck soft tissue 17 $83 $269
Foot X-ray, 3+ views 16 $6 $105
Bone density scan (DEXA) 16 $36 $215
X-ray of ankle, minimum of 3 views 15 $7 $110
Nuclear medicine study of lymphatic system 15 $44 $833
Nuclear medicine study of liver and bile duct system with use of drugs 14 $299 $973
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries 14 $33 $132
X-ray of knee, 1-2 views 12 $6 $117
Nuclear medicine study of parathyroid with spect and ct scan 12 $333 $1,800
Technetium tc-99m sestamibi, diagnostic, per study dose 12 $24 $99
Injection, sincalide, 5 micrograms 12 $90 $464
Ct scan of abdomen and pelvis before and after contrast 11 $165 $873
Nuclear medicine study of bone taken at different times 11 $274 $876
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$91
Total received (2023-2023)
Bottom 32% in TX for radiation oncology
2
Companies
2
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$91 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$91

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Telix Pharmaceuticals
$60
Novartis Pharmaceuticals Corporation
$31
Top 3 companies account for 100.0% of total payments
Associated products mentioned in payments ›
ILLUCCIX · PLUVICTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1 per 100 Medicare services performed
Looking for a radiation oncology specialist in Austin?
Compare radiation oncologists in the Austin area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
144
Per 100K population
11.0
County median income
$97,169
Nearest hospital
DELL SETON MED CENTER AT THE UNIVERSITY OF TX
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Leake is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Leake experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Leake performed 4,850 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leake receive payments from pharmaceutical companies?
Yes. Dr. Leake received a total of $91 from 2 companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leake's costs compare to other radiation oncologists in Austin?
Dr. Leake's average Medicare payment per service is $134. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leake) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →